Literature DB >> 8001600

Contribution of scintigraphy to verify the reliability of different preparation processes for enteric coated capsules.

D Catteau1, C Barthélémy, M Deveaux, H Robert, F Trublin, X Marchandise, H Van Drunen.   

Abstract

The aim of this work was to use radiopharmaceuticals such as technetium (99mTc) and indium (DTPA-Ca111In) to visualize, with a gamma-camera, the disintegration area and time of 3 types of enteric coated hard gelatin capsules (obtained by 3 different preparation processes) and thus, to verify that they are really resistant in gastric fluids and soluble in intestinal zones. Results are well correlated with those previously obtained in vitro (disintegration, dissolution) and in vivo (profiles of plasmatic concentrations versus time).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8001600     DOI: 10.1007/BF03188829

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  7 in total

1.  Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy.

Authors:  D L Casey; R M Beihn; G A Digenis; M B Shabhu
Journal:  J Pharm Sci       Date:  1976-09       Impact factor: 3.534

2.  Dissolution rate and transit times of technetium-99m DTPA-labeled tablets.

Authors:  J C Maublant; M Sournac; J M Aiache; A Veyre
Journal:  J Nucl Med       Date:  1987-07       Impact factor: 10.057

3.  Simultaneous measurement of gastric emptying of the soluble and insoluble components of a formulation using a dual isotope, gamma scintigraphic technique.

Authors:  L Kaus; H Sharma; J T Fell
Journal:  J Pharm Pharmacol       Date:  1984-02       Impact factor: 3.765

4.  The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations.

Authors:  F N Christensen; S S Davis; J G Hardy; M J Taylor; D R Whalley; C G Wilson
Journal:  J Pharm Pharmacol       Date:  1985-02       Impact factor: 3.765

5.  Monitoring in vivo disintegration time of tablets by external scintigraphy.

Authors:  M C Theodorakis; M D Devous; D R Simpson
Journal:  J Pharm Sci       Date:  1980-09       Impact factor: 3.534

6.  Radiation dose estimates for oral agents used in upper gastrointestinal disease.

Authors:  J A Siegel; R K Wu; L C Knight; R E Zelac; H S Stern; L S Malmud
Journal:  J Nucl Med       Date:  1983-09       Impact factor: 10.057

7.  Observation of portal circulation through superior mesenteric vein by enteric coated capsule of thallium-201.

Authors:  N Tonami; K Nakajima; N Watanabe; M Seto; K Yokoyama; N Shuke; T Michigishi; T Takayama; T Aburano; K Hisada
Journal:  Eur J Nucl Med       Date:  1988
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.